Lista de obras -

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

artículo científico publicado en 2015

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

artículo científico publicado en 2010

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

artículo científico publicado en 2013

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern

artículo científico publicado en 2015

Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers

scientific article published on 25 July 2016

Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding

artículo científico publicado en 2015

Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?

artículo científico publicado en 2013

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

artículo científico publicado en 2015

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

artículo científico publicado en 2009

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia

artículo científico publicado en 2016

Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration

artículo científico publicado en 2017

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

scientific article published on 04 January 2014

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease

artículo científico publicado en 2017

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

artículo científico publicado en 2015

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

artículo científico publicado en 2013

Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease

artículo científico publicado en 2013

Association of plasma and cortical amyloid beta is modulated by APOE ε4 status

scientific article published on 26 March 2013

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

artículo científico publicado en 2010

Biomarkers in frontotemporal lobar degenerations--progress and challenges

artículo científico publicado en 2011

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

artículo científico publicado en 2007

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

artículo científico publicado en 2011

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

artículo científico publicado en 2015

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2010

CSF Apo-E levels associate with cognitive decline and MRI changes

artículo científico publicado en 2014

CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?

artículo científico publicado en 2014

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects

artículo científico publicado en 2011

CSF biomarker variability in the Alzheimer's Association quality control program

artículo científico publicado en 2013

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

artículo científico publicado en 2016

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

artículo científico publicado en 2012

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

artículo científico publicado en 2013

Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative

artículo científico publicado en 2012

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

artículo científico publicado en 2010

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

artículo científico publicado en 2009

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment

artículo científico publicado en 2011

Characterizing Alzheimer's disease using a hypometabolic convergence index

artículo científico publicado en 2011

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans

artículo científico publicado en 2010

Clinical and multimodal biomarker correlates of ADNI neuropathological findings

artículo científico publicado en 2013

Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology

artículo científico publicado en 2012

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis

artículo científico publicado en 2012

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition

artículo científico publicado en 2011

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

artículo científico publicado en 2013

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

artículo científico publicado en 2011

Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms

artículo científico publicado en 2012

Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease

artículo científico publicado en 2012

Design of comprehensive Alzheimer's disease centers to address unmet national needs

artículo científico publicado en 2010

Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease

artículo científico publicado en 2016

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

artículo científico publicado en 2010

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

artículo científico publicado en 2014

Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease

artículo científico publicado en 2010

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

artículo científico publicado en 2013

Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative

artículo científico publicado en 2014

Emerging β-amyloid pathology and accelerated cortical atrophy

artículo científico publicado en 2014

Evidence for ordering of Alzheimer disease biomarkers

artículo científico publicado en 2011

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

artículo científico publicado en 2011

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease

artículo científico publicado en 2013

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

artículo científico publicado en 2017

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism

artículo científico publicado en 2016

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

artículo científico publicado en 2015

History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress

artículo científico publicado en 2014

Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

artículo científico publicado en 2015

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

artículo científico publicado en 2015

Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients

artículo científico publicado en 2012

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

artículo científico publicado en 2014

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel

artículo científico publicado en 2013

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

artículo científico publicado en 2013

Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease

artículo científico publicado en 2016

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology

artículo científico publicado en 2010

Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

scientific article published on 29 June 2013

Longitudinal change of biomarkers in cognitive decline

artículo científico publicado en 2011

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease

artículo científico publicado en 2012

Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment

artículo científico publicado en 2014

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort

artículo científico publicado en 2014

Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential

artículo científico publicado en 2014

Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls

artículo científico publicado en 2009

Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings

artículo científico publicado en 2015

Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndrome

artículo científico publicado en 2016

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition

artículo científico publicado en 2014

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

artículo científico publicado en 2015

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

artículo científico publicado en 2010

Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus

artículo científico publicado en 2012

Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease

artículo científico publicado en 2017

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker

artículo científico publicado en 2013

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

artículo científico publicado en 2012

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

artículo científico publicado en 2010

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

artículo científico publicado en 2012

Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging

artículo científico publicado en 2016

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification

artículo científico publicado en 2010

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

artículo científico publicado en 2010

Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry

artículo científico publicado en 2014

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

artículo científico publicado en 2011

Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study

artículo científico publicado en 2010

Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data

artículo científico publicado en 2011

Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI

artículo científico publicado en 2013

Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies

artículo científico publicado en 2014

Shapes of the trajectories of 5 major biomarkers of Alzheimer disease

artículo científico publicado en 2012

Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup

artículo científico publicado en 2010

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease

artículo científico

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans

artículo científico publicado en 2015

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

artículo científico publicado en 2016

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

artículo científico publicado en 2011

The Alzheimer's disease neuroimaging initiative: progress report and future plans

artículo científico publicado en 2010

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).

artículo científico publicado en 2013

The transitional association between β-amyloid pathology and regional brain atrophy

artículo científico publicado en 2014

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

artículo científico publicado en 2009

Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid

artículo científico publicado en 2011

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

artículo científico publicado en 2010

VENTRICULAR MAPS IN 804 SUBJECTS CORRELATE WITH COGNITIVE DECLINE, CSF PATHOLOGY, AND IMMINENT ALZHEIMER'S DISEASE

artículo científico publicado en 2010

Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects

artículo científico publicado en 2015

Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline

artículo científico publicado en 2010

Lista de obras de

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern

Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers

Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding

Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia

Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease

Association of plasma and cortical amyloid beta is modulated by APOE ε4 status

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

Biomarkers in frontotemporal lobar degenerations--progress and challenges

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

CSF Apo-E levels associate with cognitive decline and MRI changes

CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects

CSF biomarker variability in the Alzheimer's Association quality control program

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease

Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment

Characterizing Alzheimer's disease using a hypometabolic convergence index

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans

Clinical and multimodal biomarker correlates of ADNI neuropathological findings

Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology

Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms

Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease

Design of comprehensive Alzheimer's disease centers to address unmet national needs

Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative

Emerging β-amyloid pathology and accelerated cortical atrophy

Evidence for ordering of Alzheimer disease biomarkers

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress

Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers

Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease

Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology

Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

Longitudinal change of biomarkers in cognitive decline

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease

Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort

Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential

Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls

Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings

Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndrome

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease